Lotemax Ophthalmic Gel 0.5%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lotemax Ophthalmic Gel 0.5%, covering 2015-03-18 to 2015-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis® [Phase 4]